A Potential Turning Point for Celiac Disease: Teva’s TEV-408 Shows Promise in Phase 2a Trials
By Medical Science Correspondent For millions of individuals living with celiac disease, the current standard of care—a strict, lifelong gluten-free diet—is a demanding and often insufficient solution. Beyond the logistical…
The Collision of Ideologies: Why the "Make America Healthy Again" Promise is Colliding with "America First"
By Honor May Eldridge In the landscape of the 2024 presidential election, the American political vernacular underwent a profound transformation. Concepts that were once the domain of fringe environmentalists—the toxicity…
From Promise to Plate: The Urgent Case for Accountability in Food Safety
Families do not eat promises. They eat food placed before them, trusting that the complex, global supply chain has prioritized their health above the bottom line. This fundamental contract between…









